PMID: 9436931Jan 22, 1998Paper

Prognostic factors in multiple myeloma: practicability for clinical practice and future perspectives

Leukemia
T Haferlach, H Löffler

Abstract

Clinical staging systems for multiple myeloma published so far have not always been reliable in predicting a prognosis and do not provide important insights into the biology of the disease. Therefore, new single independent factors or their combination are needed in order to define prognostic subgroups. This is especially necessary with respect to the two treatment options such as a 'watch and wait' strategy vs autologous or even allogeneic bone marrow or stem cell transplantation. At the moment the most promising parameters for future trials and treatment decisions seem to be the plasma cell labeling index, the beta2-microglobulin and hopefully cytogenetic abnormalities that are detectable in multiple myeloma now using newer cultivation methods and fluorescence in situ hybridization in interphase plasma cells. Therefore, it is necessary to focus on these latter prognostic parameters in prospective trials when newer approaches with potentially curative therapies are administered.

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.